SEARCH BY
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 37 of 38 |
| Sector: Healthcare Services M&A | 4 of 4 |
| Type: Going Private M&A Deals | 4 of 4 |
| State: Colorado M&A | 2 of 2 |
| Country: United States M&A | 10 of 11 |
| Year: 2025 M&A | 1 of 2 |
| Size (of disclosed) | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-09 |
AnteAGE
Irvine, California, United States AnteAGE is a skincare company, developing and manufacturing science-backed skincare products based on growth factors and exosomes. Exosomes are extracellular vesicles naturally produced in the human body, that contribute to cell-to-cell communication by transferring to counterpart cells biological signals and by thus can affect and regulate cell growth, development, and repair. AnteAGE was formed in 2009 and is based in Irvine, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-07-30 |
Arkstone
Boca Raton, Florida, United States Arkstone is a biotechnology company providing clinical decision support powered by ML and AI, helping healthcare providers optimize antimicrobial use. Its OneChoice Report empowers clinicians to prescribe with precision and confidence, fighting antimicrobial resistance and democratizing infectious disease expertise. Arkstone is based in Boca Raton, Florida. |
Buy | - |
